Allergan's Q4 revenues up

Allergan’s fourth-quarter revenues rose by 6.6 percent to $4,351million. The group posted an operating loss of $276.6 million for the period compared with an operating loss of $5,384 million a year earlier. On an adjusted basis, it booked an operating income of $2.079 million, up by 8.4 percent. Allergan expects ...

Keep reading this article by becoming a member


Enjoy unrestricted access to Eyewear Intelligence

To continue reading this article subscribe now

  • Unlimited access to our highly trusted industry insights and analysis
  • Benchmark yourself against the market and competitors
  • Find inspiration to drive your business forward
  • Stay up to date with new business models and startups

If you aren’t ready to subscribe now, you can REGISTER FOR FREE. Already an Eyewear Intelligence subscriber? Sign in here.